How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,246 results for

Medication Causes of Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Headache, Diagnosis and Treatment of

: Subacute and/or progressive headaches that worsen over time (months) A new or different headache Any headache of maximum severity at onset Headache of new onset after age 50 Persistent headache precipitated by a Valsalva maneuver Evidence such as fever, hypertension, myalgias, weight loss or scalp tenderness suggesting a systemic disorder Presence of neurological signs that may suggest a secondary cause Seizures Migraine-associated symptoms are often misdiagnosed as “sinus headache” by patients (...) and clinicians. Most headaches characterized as “sinus headaches” are migraines. Early treatment of migraines with effective medications improves a variety of outcomes including duration, severity and associated disability. Drug treatment of acute headache should generally not exceed more than two days per week on a regular basis. More frequent treatment other than this may result in medication-overuse chronic daily headaches. Inability to work or carry out usual activities during a headache is an important

2013 Institute for Clinical Systems Improvement

102. Chronic pain disorder medical treatment guideline.

events. It is also likely that both transdermal medications cause less constipation than oral morphine (Design: Network meta-analysis of randomized clinical trials ). In the setting of common low back injuries, when baseline pain and injury severity are taken into account, a prescription for more than seven days of opioids in the first 6 weeks is associated with an approximate doubling of disability one year after the injury (Design: Prospective cohort study ). Some Evidence Long-acting oxycodone (...) Chronic pain disorder medical treatment guideline. Chronic pain disorder medical treatment guideline. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 08 Jun 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed

2017 National Guideline Clearinghouse (partial archive)

103. Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline.

probably causes significantly less nausea than fentanyl, and it probably carries a lower risk of treatment discontinuation due to adverse events. It is also likely that both transdermal medications cause less constipation than oral morphine (Design: Network meta-analysis of randomized clinical trials ). In the setting of common low back injuries, when baseline pain and injury severity are taken into account, a prescription for more than 7 days of opioids in the first 6 weeks is associated (...) Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline. Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline. | National Guideline Clearinghouse success fail May JUN Jul 09 2017 2018 2019 08 Jun 2018 - 09 Jun 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites

2017 National Guideline Clearinghouse (partial archive)

104. Drugs That May Cause or Exacerbate Heart Failure (Full text)

to 23 different providers annually in both the inpatient and outpatient settings, which could in turn increase the number of prescription medications prescribed. As the number of prescription medications increases, so does the potential for adverse drug events and drug-drug interactions. Goldberg et al found that patients taking at least 2 prescription medications had a 13% risk of an adverse drug-drug interaction, which increased to 38% for 4 medications and 82% with ≥7 medications. Drugs may cause (...) or exacerbate HF by causing direct myocardial toxicity; by negative inotropic, lusitropic, or chronotropic effects; by exacerbating hypertension; by delivering a high sodium load; or by drug-drug interactions that limit the beneficial effects of HF medications. To avoid these negative effects, healthcare providers need a comprehensive and accessible guide of the prescription medications, OTC medications, and CAMs that could exacerbate HF. Using case reports, case series, package inserts, meta-analyses

2016 American Heart Association PubMed

105. Headache: Common Causes and Medical Management (Full text)

Headache: Common Causes and Medical Management 13536933 2000 07 01 2018 12 01 0008-4409 78 8 1958 Apr 15 Canadian Medical Association journal Can Med Assoc J Headache: common causes and medical management. 623-6 BAILEY A A AA eng Journal Article Canada Can Med Assoc J 0414110 0008-4409 OM Disease Management Headache Humans 5834:29469:259 HEADACHE 1958 4 15 1958 4 15 0 1 1958 4 15 0 0 ppublish 13536933 PMC1829826

1958 Canadian Medical Association Journal PubMed

106. Impact of Medical Conditions and Medications on Road Traffic Safety (Full text)

Impact of Medical Conditions and Medications on Road Traffic Safety Many medical conditions and medicines with therapeutic importance have been shown to impair driving skills, causing road traffic accidents, which leads to great human and economic suffering in Oman. The primary purpose of this study was to assess retrospectively the extent of medical conditions and medications influencing road traffic safety among drivers involved in road accidents.We conducted a retrospective study among 951 (...) (9.4%). Loss of control was contributed to 38.5% of cases followed by dizziness (25.6%), sleep amnesia (10.3%), and blurred vision (7.7%). Other effects blamed by victimized drivers include vertigo, phonophobia, photophobia, back pain, loss of sensation, and headache accounting for 17.9% of cases.Medical conditions and medications influence road traffic safety to some extent in Oman.

2018 Oman medical journal PubMed

107. Medical Concepts: Acute Angle Closure Glaucoma (Full text)

Medical Concepts: Acute Angle Closure Glaucoma Acute Angle Closure Glaucoma Review - CanadiEM Medical Concepts: Acute Angle Closure Glaucoma In by Stephanie Cargnelli October 11, 2016 A 62 year old woman presents to your Emergency Department with a chief complaint of severe right eye pain. Upon further questioning, she reveals reduced vision in the affected eye and colored halos around lights. She reports a diffuse headache and two episodes of vomiting. A quick physical exam reveals significant (...) angle closure glaucoma is an important cause of headache in the adult, and can be missed if not included in your differential diagnosis. While some of the physical examination findings are admittedly difficult to appreciate, measurement of the patient’s IOP with the Tonopen is simple and essential to making the diagnosis. The pharmacologic treatments listed in the article can temporize the patient, especially if you are in a centre without quick access to an Ophthalmologist, however

2016 CandiEM PubMed

108. Safinamide (Xadago) for advanced Parkinson´s disease. ON Symptoms / LOW Evidence / OFF Medication

disease Safety Adverse reactions The most common adverse effects of safinami - de include: CNS (dyskinesia, headache, drow- siness, etc.), gastrointestinal (nausea and vo- miting), musculoskeletal and vision (cataract, retinopathy) problems. Unlike most adverse effects, orthostatic hypotension tended to in- crease with higher doses of safinamide. Mor - tality with safinamide was 2.6% (1.7 per 100 persons-year) vs. 1.2% (1.3 per 100 persons- year) with placebo p=0.02. The most frequent causes of death (...) Safinamide (Xadago) for advanced Parkinson´s disease. ON Symptoms / LOW Evidence / OFF Medication Indications Safinamide is indicated for the treatment of adult patients with idiopathic Parkinson’s di- sease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid- to late-stage fluctuating patients. Mechanism of action and pharmacokinetics Safinamide is a selective reversible inhibitor of monoamine oxidase B (MAO-B) inhibitor

2016 Drug and Therapeutics Bulletin of Navarre (Spain)

109. Lies My Patients Told Me: ?I Take My Medications Every Day.?

my medicine. I do not take my medicines when I am feeling sad or upset. My medicines disrupt my life. When my medicine causes minor side effects, I stop taking it. The idea of taking medications for the rest of my life makes me very uncomfortable. The tool is practical, efficient, and patient-centered–all of the things I strive to be. However, as it has only been publicized within the past month, I’d like to see some more validity testing before investing in the MeDS scale myself. Part (...) Lies My Patients Told Me: ?I Take My Medications Every Day.? Lies My Patients Told Me: “I Take My Medications Every Day.” – Clinical Correlations Search Lies My Patients Told Me: “I Take My Medications Every Day.” January 15, 2016 4 min read By Rebecca Sussman Peer Reviewed Reviewing medical evidence has become such a habit that sometimes it feels almost impossible to think independently. I’ve always been a top-down thinker; I go with my gut instinct, and then look for the evidence to support

2016 Clinical Correlations

110. Clearing the Smoke on Cannabis: Medical Use of Cannabis and Cannabinoids ? An Update

the body, cannabinoids can cause a number of changes in body functions. Therefore, the use of cannabinoids for therapeutic action is almost always accompanied to some degree by side-effects. Medically Used Preparations and Methods of Administration In Canada, cannabis for medical purposes is legally accessed through the Access to Cannabis for Medical Purposes Regulations (ACMPR). Because the cannabis accessed through this program is monitored and standardized, it is less risky to use than cannabis (...) that is both a blocker of CB 1 receptors outside the brain and an inhibitor of an enzyme called nitric oxide synthase has been found to markedly reduce fibrosis of the liver caused by hepatitis virus, by alcohol or by toxic chemicals in mice (Kunos, 2016). These are all interesting possibilities with some scientific rationale, but they have not yet been explored clinically. 3. Treatment of Symptoms versus Treatment of Disease In most of the medical uses or potential uses described above, cannabis

2016 Canadian Centre on Substance Abuse

111. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity ENDOCRINE PRACTICE Vol 22 (Suppl 3) July 2016 1 AACE/ACE Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY W. Timothy Garvey, MD, FACE 1 ; Jeffrey I. Mechanick, MD, FACP , FACE, FACN, ECNU 2 (...) ; Elise M. Brett, MD, FACE, CNSC, ECNU 3 ; Alan J. Garber, MD, PhD, FACE 4 ; Daniel L. Hurley, MD, FACE 5 ; Ania M. Jastreboff, MD, PhD 6 ; Karl Nadolsky, DO 7 ; Rachel Pessah-Pollack, MD 8 ; Raymond Plodkowski, MD 9 ; and Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines* American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically devel- oped statements to assist health care professionals in medical decision-making for specific clinical

2016 American Association of Clinical Endocrinologists

112. American football and other sports injuries may cause migraine/persistent pain decades later and can be treated successfully with electrical twitch-obtaining intramuscular stimulation (ETOIMS) (Full text)

levels are negatively related to twitch force, number of treatments, treatment session duration and directly related to BP and heart rate/pulse. Treatment numbers and session durations directly influence twitch force. At end of study, headaches and quality of life improved, hypertension resolved and antihypertensive medication had been discontinued.Using statistical process control methodology in an individual patient, we showed long-term safety and effectiveness of ETOIMS in simultaneous diagnosis (...) American football and other sports injuries may cause migraine/persistent pain decades later and can be treated successfully with electrical twitch-obtaining intramuscular stimulation (ETOIMS) Autonomous twitch elicitation at myofascial trigger points from spondylotic radiculopathies-induced denervation supersensitivity can provide favourable pain relief using electrical twitch-obtaining intramuscular stimulation (ETOIMS).To provide objective evidence that ETOIMS is safe and efficacious

2017 BMJ innovations PubMed

113. Cervico-cephalalgiaphobia: a subtype of phobia in patients with cervicogenic headache and neck pain? A pilot study (Full text)

treatment', 'Shorter interval between treatment sessions', 'Fear of "locked facet joints" of the neck', 'More frequent manipulation', and 'Fear of increase in headaches'. Coverage was also substantial for 'never' regarding 'Long-term positive results in previous manual physical therapeutic treatment'. 'Confirmation of "locked facet joints" of the cervical spine by MPT as a cause for increase of CEH' scored 'often/always' in all patients. Coverage for 'Increased use of medication with insufficient effect (...) Cervico-cephalalgiaphobia: a subtype of phobia in patients with cervicogenic headache and neck pain? A pilot study The term 'cephalalgiaphobia' was introduced in the mid-1980s and defined as fear of migraine (attacks). We hypothesized that a specific subtype of cephalalgiaphobia affects patients with cervicogenic headache (CEH). This study aimed to: (1) define the term 'cervico-cephalalgiaphobia'; (2) develop a set of indicators for phobia relevant to patients with CEH; and (3) apply this set

2016 The Journal of manual & manipulative therapy PubMed

114. Prazosin for Post-Concussive Headaches

Care System Madigan Army Medical Center Information provided by (Responsible Party): Seattle Institute for Biomedical and Clinical Research Study Details Study Description Go to Brief Summary: Mild traumatic brain injury (mTBI) caused by blast effects of explosive devices has been called the "signature injury" of soldiers who served in the Iraq and Afghanistan conflicts. mTBI can also occur from impact or hitting the head on an object or the ground. Although termed "mild" in comparison to major (...) brain injuries, people with mTBI can have problems with their memory and concentration. People with mTBI can also find they are more irritable, have more anxiety, and have trouble with their mood and sleep. The purpose of this study is to see if a medication called prazosin can help treat chronic headaches in people with mTBI. The Food and Drug Administration (FDA) has approved prazosin for treating people with high blood pressure. At this time, the FDA has not approved prazosin in the treatment

2016 Clinical Trials

115. Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department

efficacious and efficient. Haloperidol (Haldol), a butyrophenone class of medication, is thought to act by affecting the dopamine 2 receptor in the brain. By exploring haloperidol as an option for treatment, the investigators hope to discover a more efficient and effective medication for the treatment of non-traumatic headaches, thereby decreasing a patient's length of stay in the department and decreasing the rate of return visits for continued discomfort from the same headache. This study could lead (...) to the increased usage of haloperidol as a first line agent in the treatment of prolonged headaches presenting to the ED. Condition or disease Intervention/treatment Phase Headache, Migraine Drug: Metoclopramide Drug: Haloperidol Other: Normal Saline Drug: Diphenhydramine Phase 4 Detailed Description: At this time, choice of medications for the treatment of headaches in the ED is still based on personal and patient preferences because no properly constructed trials have been carried out that would allow

2016 Clinical Trials

116. Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

with a headache, would you wish to receive the same IV fluid treatment again?" Need for rescue medication [ Time Frame: 120 minutes ] Need for additional medications for pain control as determined by the treating physician. Length of stay [ Time Frame: 1 day ] Length of emergency department stay Pain score at 48 hours [ Time Frame: 48 hours ] Current pain as reported by participants at 48 hour follow-up (0-10 verbal scale). Nausea [ Time Frame: 60 mins, 120 mins ] Patients will be asked to describe (...) of the following four characteristics: unilateral location pulsating quality moderate or severe pain intensity aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs) D. During headache at least one of the following: nausea and/or vomiting photophobia and phonophobia E. Not better accounted for by another ICHD-3 diagnosis. Exclusion Criteria: Intravenous Fluids are contraindicated in the opinion of the emergency department physician caring for the patient (ex patient

2016 Clinical Trials

117. Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches

Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Precutaneous (...) High Risk Patent Foramen Ovale to Treat Migraine Headaches The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02777359 Recruitment Status : Recruiting First Posted : May 19, 2016 Last Update Posted : July 19, 2017 See

2016 Clinical Trials

118. What you need to know about migraine headaches in children

, or prescription medications called “triptans.” All of these work best if taken very soon after any migraine symptoms start. But all of these are also prone to causing “rebound headaches” if taken too frequently. So, again, prevention is better than cure. (Still, a cure is nice to have if you need one!) By the way, narcotic medications should never be used to treat migraines, especially in children — they headaches, start by keeping a log to track potential triggers and causes. Don’t discount the role of stress, even if your child “doesn’t seem stressed.” And try to encourage good, regular sleep and eating habits. Still having headaches? It’s time to see the doctor. Even if daily medications don’t show much promise, we’ve got other good options to both prevent and treat migraines in children. Roy Benaroch is a pediatrician who blogs at the . He is also the author

2016 KevinMD blog

119. An Algorithm for Opioid and Barbiturate Reduction in the Acute Management of Headache in the Emergency Department. (Full text)

An Algorithm for Opioid and Barbiturate Reduction in the Acute Management of Headache in the Emergency Department. To develop and implement an algorithm for the management of headaches presenting to the emergency department (ED) in order to decrease the frequency of opioid and barbiturate treatment both acutely as well as on discharge.Headache is the fifth leading cause of ED visits in the United States. In the case of primary headache, particularly migraine, treatment in the ED can be highly (...) variable. Patients with migraine continue to be treated with opioids more commonly than nonopioid, migraine specific medications. In addition, discharge plans seldom include measures to prevent recurrence or instructions to re-treat if pain persists. At this time, there is no standardized management protocol directed at acute headaches presenting to the ED.An ED headache treatment algorithm with step-wise instructions for diagnosis, treatment, and discharge planning was piloted at Lakewood Hospital

2016 Headache PubMed

120. Headache Prevalence at 4-11 Years After Deployment-Related Traumatic Brain Injury in Veterans of Iraq and Afghanistan Wars and Comparison to Controls: A Matched Case-Controlled Study. (PubMed)

deployment for CS, the TBIS as compared to CS suffered much more frequent and severe headaches. For TBIS, there was no relation of headache intensity or phenotype to severity or cause of the TBI, and the Headache Burden has not improved over time up to 11 years after D-TBI. The process initiated by the D-TBI that relates to the headache has a prolonged effect up to and beyond 11 years.© 2016 American Headache Society. (...) Headache Prevalence at 4-11 Years After Deployment-Related Traumatic Brain Injury in Veterans of Iraq and Afghanistan Wars and Comparison to Controls: A Matched Case-Controlled Study. Evaluate the extent and severity of headache following deployment-related TBI (D-TBI) in veterans of the Iraq (OIF) and Afghanistan (OEF) wars over a follow-up period of 4-11 years with comparison to age, sex, race, and time of deployment matched controls.TBI has been recognized as the "signature Injury

2016 Headache

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>